Compositions and methods for expression of il-12 and il-1ra
AssigneeReplicate Bioscience, Inc.
InventorsNathaniel Stephen WANG, Shigeki Joseph MIYAKE-STONER, Parinaz ALIAHMAD
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the field of molecular virology, and particularly relates to nucleic acid molecules encoding a modified alphavirus virus viral genome or self-replicating RNA (srRNA) construct, pharmaceutical compositions containing the same, and the use of such nucleic acid molecules and compositions for production of desired products in cell cultures or in a living body. Also provided are methods for eliciting a pharmacodynamics effect in a subject.
Claims26
A nucleic acid construct comprising a nucleic acid sequence encoding a modified alphavirus genome or self-replicating RNA (srRNA), wherein at least a portion of the nucleic acid sequence encoding the viral structural proteins of the modified alphavirus genome or srRNA has been replaced by a coding sequence for a polypeptide construct comprising:
- a) a coding sequence for a p35 subunit of interleukin 12 (p35 or IL-12A) or a functional variant thereof;
- b) a coding sequence for a p40 subunit of interleukin 12 (p40 or IL-12B) or functional variant thereof;
- and
- c) a coding sequence for an interleukin-1 receptor antagonist (IL-1RA) or a functional variant thereof.
- wherein the coding sequences for IL-12A, IL-12B, and IL-1RA are operably linked to one another.
Dependencies are inferred from the claim text.